Ekihiro Seki to Sirolimus
This is a "connection" page, showing publications Ekihiro Seki has written about Sirolimus.
Connection Strength
0.226
-
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. J Clin Invest. 2014 Aug; 124(8):3566-78.
Score: 0.113
-
Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab. 2014 Jul 01; 20(1):133-44.
Score: 0.113